Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organoheterocyclic compounds
  6. Quinolines and derivatives
  7. SB 222200, Tocris Bioscience™

SB 222200, Tocris Bioscience™

Catalog No. p-4785525 Shop All R&D Systems Products
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Description

Potent, selective non-peptide NK3 antagonist. Brain penetrant

Potent and selective non-peptide NK3 receptor antagonist (Ki values are 4.4, > 100,000 and 250 nM for human NK3, NK1 and NK2 receptors respectively). Antihypertensive in vivo. Brain penetrant.

Chemical Identifiers

CAS 174635-69-9
Molecular Formula C26H24N2O
Molecular Weight (g/mol) 380.491
InChI Key MQNYRKWJSMQECI-QFIPXVFZSA-N
Synonym 3-methyl-2-phenyl-n-1s-1-phenylpropyl quinoline-4-carboxamide, chembl10284, s-3-methyl-2-phenyl-n-1-phenylpropyl-4-quinolinecarboxamide, 3-methyl-2-phenyl-n-1s-1-phenylpropyl-4-quinolinecarboxamide, s-3-methyl-2-phenyl-n-1-phenylpropyl quinoline-4-carboxamide, 4-quinolinecarboxamide, 3-methyl-2-phenyl-n-1s-1-phenylpropyl, tocris-1393, lopac-s-5192, d00vpt
PubChem CID 6604009
IUPAC Name 3-methyl-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide
SMILES CCC(C1=CC=CC=C1)NC(=O)C2=C(C(=NC3=CC=CC=C32)C4=CC=CC=C4)C

Specifications

Quantity 10 mg
Formula Weight 380.48
Percent Purity >98%
Chemical Name or Material SB 222200

Safety and Handling

Recommended Storage Store at Room Temperature
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.